학술논문

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Document Type
Letter
Source
In: Leukemia. (Leukemia, April 2024, 38(4):918-922)
Subject
Language
English
ISSN
14765551
08876924